Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Inherited Retinal Disease Market In The Coming Years?

There has been a robust growth in the market size of inherited retinal diseases in the past few years. The market is projected to climb from $11.56 billion in 2024 to $12.54 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. The growth experienced in the historical period can be linked to factors like gene therapy utilization, incentivised regulatory practices, increase in patient registry growth, a surge in clinical trials, and an escalation in patient-oriented solutions.

Anticipated robust expansion is projected for the inherited retinal disease market in the coming years, growing to a substantial $17.26 billion by 2029 with a compound annual growth rate (CAGR) of 8.3%. This anticipated surge over the forecasted period can be tied back to factors such as increased implementation of CRISPR, the initiation of customized treatments, emphasis on regenerative medicine, escalating patient advocacy, and efforts aimed at enhancing patient life quality. Foreseen trends for the period consist of progress in the field of optogenetics technology, the invention of synthetic retina implants, the growth of digital health platforms, blending of artificial intelligence in disease simulation, and the application of artificial intelligence in devising treatments.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Inherited Retinal Disease Market?

The escalating cases of macular degeneration is projected to fuel the expansion of the inherited retinal disease market. Macular degeneration is a condition linked to age, which impairs the macula, leading to the loss of central vision and making tasks like reading or recognizing faces challenging. The rise in instances of macular degeneration is attributed to aging populations, enhanced life expectancy, and lifestyle factors like smoking and poor nutrition that raise risk levels. Inherited retinal disease treatments aid macular degeneration patients by pinpointing and treating the genetic causes of retinal degeneration, providing therapies to slow the progression of the disease, restore lost vision, or even fend off additional damage to the retina, essentially enhancing visual outcomes and quality of life for people affected by age-related or inherited macular degeneration. For example, in February 2024, the Canadian Ophthalmological Society, a nonprofit organization based in Canada, stated that 2.5 million Canadians aged 55 and older, lost their vision due to age-related macular degeneration (AMD). Therefore, the escalating cases of macular degeneration are spurring the expansion of the inherited retinal disease market.

Which Sub-Segments Are Driving Growth Within The Inherited Retinal Disease Market?

The inherited retinal diseasemarket covered in this report is segmented –

1) By Type: Diagnosis; Therapy

2) By Disease Type: Retinitis Pigmentosa; Choroideremia; Stargardt Disease; Cone-rode Dystrophy; Leber Congenital Amaurosis; Other Diseases

3) By Distribution Channel: Retail Sales; Direct Tender

4) By End Users: Hospitals; Speciality Clinics; Ambulatory Surgical Centres; Home Healthcare; Other End Users

Subsegments:

1) By Diagnosis: Genetic Testing (Genetic Screening); Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)); Electrophysiological Testing (Electroretinography); Visual Field Testing; Fundus Autofluorescence Imaging

2) By Therapy: Gene Therapy; Stem Cell Therapy; Retinal Prosthesis (Artificial Retina); Pharmacological Therapy (Gene Editing, Retinal Drugs); Photoreceptor Rescue Therapy

What Key Trends Are Driving Growth In The Inherited Retinal Disease Market?

Prominent enterprises in the inherited retinal diseases market are concentrating their efforts on the creation of novel treatments such as mutation-agnostic gene therapy. This approach is designed to offer comprehensive therapies and address an extensive spectrum of genetic variations related to these diseases. Rather than focusing on specific mutations, mutation-agnostic gene therapy targets broader genetic structures or pathways, making it suitable for a wide array of genetic maladies. For example, Nanoscope Therapeutics Inc, a biotechnology firm based in the United States, revealed encouraging results in March 2024 from the clinical trial of their main program, MCO-010. This therapy showed significant vision enhancement for patients suffering from profound and permanent vision loss due to advanced retinitis pigmentosa. MCO-010 reached its fundamental and major secondary objectives with statistical significance, without triggering serious adverse consequences.

Which Players Are Shaping The Competitive Landscape Of The Inherited Retinal Disease Market?

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

How Do Regional Dynamics Influence The Inherited Retinal Disease Market Performance?

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp

Browse Through More Reports Similar to the Global Inherited Retinal Disease Market 2025, By The Business Research Company

Vitreoretinal Surgery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vitreoretinal-surgery-devices-global-market-report

Retinal Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Retinal Disorder Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model